HSPA5 and renal cell carcinoma: In this study, we show that ER stress responses are activated during anti-angiogenic therapy and that inhibition of the UPR by GRP78 knockdown potently suppresses tumor progression and enhances the antitumor effects of anti-angiogenic therapy in RCC both in vitro and in vivo.